What question did this study set out to answer?

The aim is to explore how machine learning can improve the discovery of selective cannabinoid ligands.

April 24, 2026

Leveraging machine learning for selective cannabinoid ligand discovery: methods, challenges, and opportunities

BLBailang LiuUnited States Food and Drug Administration JLJie LiuNational Center for Toxicological Research WGWenjing GuoUnited States Food and Drug Administration

Key Points

The aim is to explore how machine learning can improve the discovery of selective cannabinoid ligands.
Utilized machine learning approaches for predicting cannabinoid receptor selectivity
Addressed challenges like data quality and endpoint inconsistency
Proposed integrating curated datasets and generative AI frameworks
Highlighted the constraints in current cannabinoid ligand discovery
Emphasized the potential of improved data quality and mechanistic modeling
Indicated that future methods could elevate the development of cannabinoid therapeutics

Abstract

ML has significantly advanced the prediction of cannabinoid receptor selectivity, yet progress remains constrained by data quality, endpoint inconsistency, and limited interpretability. Future efforts integrating curated datasets, mechanistically informed modeling, and generative AI frameworks are expected to substantially enhance the discovery of selective cannabinoid therapeutics.

Ask AI

Helpful

Bookmark

View Full Paper